サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763266

再溶解薬向けバイアルアダプターの世界市場

Vial Adaptors for Reconstitution Drug

出版日
ページ情報
英文 223 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
再溶解薬向けバイアルアダプターの世界市場
出版日: 2025年07月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 223 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

再溶解薬向けバイアルアダプターの世界市場は2030年までに21億米ドルに達する

2024年に15億米ドルと推定される再溶解薬向けバイアルアダプターの世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には21億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるポリカーボネートは、CAGR 6.8%を記録し、分析期間終了時には13億米ドルに達すると予測されます。シリコンセグメントの成長率は、分析期間中CAGR 3.9％と推定されます。

米国市場は4億130万米ドルと推定、中国はCAGR 5.9％で成長予測

米国の再溶解薬向けバイアルアダプター市場は、2024年に4億130万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3億2,460万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.9%と4.7%と予測されています。欧州では、ドイツがCAGR 5.0%で成長すると予測されています。

世界の再溶解薬向けバイアルアダプター市場- 主要動向と市場促進要因を探る

なぜ再溶解薬向けバイアルアダプターシステムはドラッグデリバリーに革命をもたらすのか？

再溶解薬向けバイアルアダプターは、医薬品のパッケージングやドラッグデリバリー・システムにおいて、凍結乾燥した薬剤を再溶解し、シリンジに移すための効率的で安全な方法を提供する不可欠なコンポーネントとして登場しました。しかし、これらのデバイスが現代のヘルスケア環境において非常に重要である理由は何でしょうか？バイアルアダプターは、バイアルとシリンジ間の安全で針のないインターフェースを提供するように設計された特殊なアタッチメントであり、再溶解された薬剤の混合および抽出のプロセスを簡素化します。これらのアダプターは主に、投与前に希釈剤と混合する必要がある凍結乾燥薬剤の再溶解に使用されます。バイアルアダプターは針を必要とせず、針刺し傷害のリスクを低減し、薬液の無菌的移送を保証します。汚染を防ぐクローズドシステムを提供することで、医療従事者と患者の安全性を高めると同時に、薬剤の再溶解と移動のプロセスを通じて薬剤の完全性を維持することを保証します。

バイアルアダプターの需要は、市場に参入する生物製剤や凍結乾燥薬剤の増加によって牽引されています。ワクチン、ホルモン、モノクローナル抗体などの生物製剤は、使用前にしばしば再溶解を必要とします。バイアルアダプターは、薬剤調製の複雑さを軽減し、投与ミスのリスクを最小限に抑え、正確なドラッグデリバリーを保証する、ユーザーフレンドリーで信頼性の高いソリューションを提供することにより、このプロセスを簡素化します。これらのアダプターの使用は病院やクリニックに限定されるものではなく、患者や介護者が薬剤を管理する在宅ヘルスケア環境でも普及しつつあります。糖尿病、関節リウマチ、多発性硬化症などの慢性疾患の増加により、生物学的製剤の自己投与の傾向が強まっていることが、バイアルアダプターの採用をさらに加速させています。自己投与される注射薬の数が増え続ける中、バイアルアダプターは、薬剤の再溶解と投与の安全性と利便性を高める上で、さらに重要な役割を果たすことになるでしょう。

技術の進歩は、どのように再溶解薬向けバイアルアダプターの性能を高めているのでしょうか？

再溶解薬向けバイアルアダプター市場では、これらのデバイスの安全性、効率性、使いやすさを向上させる数々の技術的進歩が見られます。しかし、こうした開発の原動力となっている主な技術革新とは何だろうか。最も重要な進歩の1つは、バイアルとシリンジを1つの充填済みユニットに統合したデュアルチャンバー再溶解システムの開発です。これらのシステムにより、ユーザーはバイアルをシリンジから取り外すことなく薬剤と希釈剤を混合することができ、再溶解に必要なステップ数を減らし、汚染のリスクを最小限に抑えることができます。デュアルチャンバーシステムは、安定性と有効性を維持するために正確な混合を必要とする生物製剤やその他の繊細な製剤に特に有益です。セルフシールエラストマーや一体型フィルターなどの高度なシーリング技術の導入により、バイアルアダプターの性能はさらに向上し、空気の侵入を防ぎ、再溶解中に閉鎖された無菌環境を維持することができるようになりました。

もう一つの重要な技術革新は、ニードルフリーのコネクターを内蔵したバイアルアダプターの設計です。これらのアダプターは、ルアーロック機構を使用してシリンジや輸液セットに確実に取り付けられるため、注射針を必要とせず、再溶解された薬剤の移送が容易になります。この針のないデザインは、針刺し傷害のリスクを低減するだけでなく、医療従事者のワークフローを簡素化し、薬剤の調製と投与をより迅速かつ効率的にします。また、明確な視覚的インジケーターとクリック音を備えたアダプターの開発により、ユーザーは安全な接続を即座に確認できるようになり、使い勝手が向上しました。さらに、材料科学の進歩により、さまざまな薬剤や溶媒に適合する生体適合性、耐薬品性に優れた材料からバイアルアダプターが製造されるようになりました。これらの材料は、アダプターが製剤と反応しないことを保証し、製剤の安定性と完全性を保ちます。これらの技術の統合により、より安全で信頼性が高く、使いやすいバイアルアダプターが生まれ、さまざまな環境におけるヘルスケアプロバイダーや患者の多様なニーズに応えています。

どのような市場動向が、ヘルスケア環境全体における再溶解薬向けバイアルアダプターの採用を促進しているか？

医療従事者、患者、製薬メーカーの進化するニーズや嗜好を反映し、いくつかの主要な市場動向がヘルスケア環境全体における再溶解薬向けバイアルアダプターの採用を形成しています。最も顕著な動向の1つは、生物学的製剤や特殊薬剤の使用の増加であり、これらはしばしば投与前に再溶解を必要とします。モノクローナル抗体、ワクチン、細胞・遺伝子治療薬などの生物学的製剤は通常、保存期間と安定性を延ばすために凍結乾燥されます。生物製剤の市場が拡大し続ける中、安全性と無菌性を確保しながら薬剤の調製を簡素化する再溶解ソリューションの必要性が高まっています。バイアルアダプターは、医療従事者や患者を潜在的な汚染や針刺し損傷にさらすことなく、安全で容易な再溶解を可能にする理想的なソリューションを提供します。この傾向は、複雑な治療薬の調製や投与が頻繁に行われる病院や専門薬局の分野で特に強くなっています。

バイアルアダプターの採用を促進するもう一つの重要な動向は、在宅ヘルスケアと注射療法の自己投与の増加です。糖尿病、多発性硬化症、自己免疫疾患などの慢性疾患の蔓延に伴い、自宅で自己投与可能な生物学的製剤の投与を受ける患者が増加しています。バイアルアダプターは、薬剤を再溶解してシリンジに注入するためのシンプルで直感的なインターフェースを提供することにより、このプロセスを容易にします。これにより、複雑な薬剤調製ステップの必要性が減り、患者にとって自己投与がより安全で便利になります。患者中心のケアへのシフトと通院回数の削減の重視が、在宅ヘルスケア現場でのバイアルアダプターの採用をさらに後押ししています。この動向は、手作業による組み立ての必要性をなくし、取り扱いミスのリスクを軽減するプレフィルドおよびプレアタッチドバイアルアダプターシステムの開発にも反映されています。これらの動向は、よりユーザーフレンドリーで患者中心のドラッグデリバリーソリューションへの幅広いシフトを浮き彫りにしており、バイアルアダプターを薬剤投与の将来における重要なコンポーネントとして位置づけています。

世界の再溶解薬向けバイアルアダプター市場の成長を促進する要因は？

世界の再溶解薬向けバイアルアダプター市場の成長は、生物学的製剤に対する需要の高まり、患者の安全性への関心の高まり、自己投与や在宅ヘルスケアの利用拡大など、いくつかの要因によってもたらされます。主な成長要因の1つは、使用前に再溶解を必要とする生物学的製剤やワクチンの数が増加していることです。製薬業界が複雑な疾患を治療するための生物学的製剤や特殊薬剤にシフトするにつれ、信頼性の高い再溶解ソリューションへの需要が高まっています。バイアルアダプターは、これらの薬剤を再溶解するための安全で効率的な方法を提供し、正確な投与を保証し、汚染のリスクを低減します。バイアルアダプターは微生物汚染のリスクを最小化し、調製・投与中の医薬品の無菌性を確保するのに役立つため、ヘルスケア環境における感染予防と管理の重視の高まりも主要な促進要因となっています。

もう一つの重要な成長要因は、より安全な医薬品取扱いの必要性に対応するため、無針および閉鎖系移送装置（CSTD）の採用が増加していることです。無針バイアルアダプターは、薬剤の再溶解や移送時に針を使用しないように設計されており、針刺し損傷や偶発的な曝露のリスクを低減します。バイアルアダプターを含むCSTDは、安全性が最優先される化学療法剤などの危険な薬剤の取り扱いに広く使用されています。針刺し損傷とその潜在的な健康リスクに対する意識の高まりは、針を使わないシステムに対する規制当局の支持を高め、病院と外来患者の両方の環境におけるバイアルアダプターの採用をさらに促進しています。さらに、アジア太平洋やラテンアメリカなどの新興市場におけるヘルスケアインフラの拡大と医療費の増加は、バイアルアダプター市場の成長に新たな機会をもたらしています。これらの地域では、高度なヘルスケアソリューションへのアクセス改善と医薬品製造能力の拡大に投資しているため、バイアルアダプターの需要は大幅に増加すると予想されます。

世界のバイアルアダプター市場は、薬剤の再溶解および投与プロセスにおける標準化と自動化の動向からも恩恵を受けています。製薬会社は、一貫した製品品質を確保し、エンドユーザーの再溶解プロセスを簡素化するため、ドラッグデリバリーシステムにバイアルアダプターを組み込むケースが増えています。この動向は、プレフィルドシリンジやペン型注射器のような配合剤の開発において特に顕著であり、バイアルアダプターは混合や移送を容易にするために使用されています。技術の進歩が続き、生物学的製剤に対する需要が高まる中、世界の市場力学は、技術革新、規制当局の支援、進化するヘルスケア慣行のダイナミックな相互作用によって、持続的な成長を遂げる態勢を整えています。

セグメント

素材（ポリカーボネート、シリコン、ポリエチレンテラフタレートグリコール、ポリエチレン、その他素材）、治療領域（自己免疫疾患、感染症、代謝疾患、生殖医療、その他治療領域）

調査対象企業の例

  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Sensile Medical AG
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16893

Global Vial Adaptors for Reconstitution Drug Market to Reach US$2.1 Billion by 2030

The global market for Vial Adaptors for Reconstitution Drug estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Silicon segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$401.3 Million While China is Forecast to Grow at 5.9% CAGR

The Vial Adaptors for Reconstitution Drug market in the U.S. is estimated at US$401.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$324.6 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Vial Adaptors for Reconstitution Drug Market - Key Trends & Growth Drivers Explored

Why Are Vial Adaptors for Reconstitution Drug Systems Revolutionizing Drug Delivery?

Vial adaptors for reconstitution drugs have emerged as essential components in pharmaceutical packaging and drug delivery systems, offering an efficient and safer method for reconstituting lyophilized drugs and transferring them into syringes. But what makes these devices so critical in modern healthcare settings? Vial adaptors are specialized attachments designed to provide a secure, needle-free interface between a vial and a syringe, simplifying the process of mixing and drawing reconstituted drugs. These adaptors are primarily used for reconstituting lyophilized (freeze-dried) drugs that must be mixed with a diluent before administration. Vial adaptors eliminate the need for needles, reducing the risk of needlestick injuries and ensuring aseptic transfer of the drug solution. By providing a closed system that prevents contamination, they enhance safety for healthcare providers and patients while ensuring that the drug maintains its integrity throughout the reconstitution and transfer process.

The demand for vial adaptors is being driven by the increasing number of biologics and lyophilized drugs entering the market. Biologics, which include vaccines, hormones, and monoclonal antibodies, often require reconstitution before use. Vial adaptors simplify this process by providing a user-friendly and reliable solution that reduces the complexity of drug preparation, minimizes the risk of dosing errors, and ensures accurate drug delivery. The use of these adaptors is not limited to hospitals and clinics; they are also becoming more prevalent in home healthcare settings, where patients or caregivers administer medications. The growing trend towards self-administration of biologic therapies, driven by the rise of chronic conditions such as diabetes, rheumatoid arthritis, and multiple sclerosis, has further accelerated the adoption of vial adaptors. As the number of self-administered injectable drugs continues to increase, vial adaptors are poised to play an even more significant role in enhancing the safety and convenience of drug reconstitution and administration.

How Are Technological Advancements Elevating the Performance of Vial Adaptors for Reconstitution Drugs?

The vial adaptors for reconstitution drug market have witnessed numerous technological advancements that have enhanced the safety, efficiency, and usability of these devices. But what are the key innovations driving these developments? One of the most significant advancements is the development of dual-chamber reconstitution systems that integrate a vial and syringe into a single, pre-filled unit. These systems enable users to mix the drug and diluent without removing the vial from the syringe, reducing the number of steps required for reconstitution and minimizing the risk of contamination. Dual-chamber systems are particularly beneficial for biologics and other sensitive formulations that require precise mixing to maintain stability and efficacy. The incorporation of advanced sealing technologies, such as self-sealing elastomers and integrated filters, has further improved the performance of vial adaptors by preventing air ingress and maintaining a closed, sterile environment during reconstitution.

Another critical innovation is the design of vial adaptors with integrated needle-free connectors. These adaptors use a luer-lock mechanism to securely attach to syringes and IV sets, facilitating the transfer of reconstituted drugs without the need for needles. This needle-free design not only reduces the risk of needlestick injuries but also simplifies the workflow for healthcare providers, making drug preparation and administration faster and more efficient. The development of adaptors with clear visual indicators and audible clicks has also enhanced their usability, providing users with immediate confirmation of a secure connection. Furthermore, advancements in materials science have led to the production of vial adaptors made from biocompatible, chemical-resistant materials that are compatible with a wide range of drugs and solvents. These materials ensure that the adaptors do not react with the drug formulation, preserving its stability and integrity. The integration of these technologies has resulted in safer, more reliable, and user-friendly vial adaptors that cater to the diverse needs of healthcare providers and patients in various settings.

What Market Trends Are Driving the Adoption of Vial Adaptors for Reconstitution Drugs Across Healthcare Settings?

Several key market trends are shaping the adoption of vial adaptors for reconstitution drugs across healthcare settings, reflecting the evolving needs and preferences of healthcare providers, patients, and pharmaceutical manufacturers. One of the most prominent trends is the increasing use of biologic therapies and specialty drugs, which often require reconstitution before administration. Biologic drugs, such as monoclonal antibodies, vaccines, and cell and gene therapies, are typically lyophilized to extend their shelf life and stability. As the market for biologics continues to expand, there is a growing need for reconstitution solutions that simplify drug preparation while ensuring safety and sterility. Vial adaptors provide an ideal solution by enabling safe and easy reconstitution without exposing healthcare providers or patients to potential contamination or needlestick injuries. This trend is particularly strong in the hospital and specialty pharmacy sectors, where complex therapies are frequently prepared and administered.

Another significant trend driving the adoption of vial adaptors is the rise of home-based healthcare and self-administration of injectable therapies. With the growing prevalence of chronic diseases like diabetes, multiple sclerosis, and autoimmune disorders, more patients are receiving biologic therapies that can be self-administered at home. Vial adaptors facilitate this process by providing a simple and intuitive interface for reconstituting and drawing medications into syringes. This reduces the need for complex drug preparation steps and makes self-administration safer and more convenient for patients. The shift towards patient-centric care and the emphasis on reducing hospital visits have further supported the adoption of vial adaptors in home healthcare settings. The trend is also reflected in the development of pre-filled and pre-attached vial adaptor systems, which eliminate the need for manual assembly and reduce the risk of handling errors. These trends highlight a broader shift towards more user-friendly and patient-centric drug delivery solutions, positioning vial adaptors as a key component in the future of drug administration.

What Factors Are Driving the Growth of the Global Vial Adaptors for Reconstitution Drug Market?

The growth in the global vial adaptors for reconstitution drug market is driven by several factors, including the rising demand for biologic therapies, the increasing focus on patient safety, and the expanding use of self-administration and home healthcare. One of the primary growth drivers is the growing number of biologic drugs and vaccines that require reconstitution before use. As the pharmaceutical industry shifts towards biologics and specialty drugs for treating complex diseases, the demand for reliable reconstitution solutions has increased. Vial adaptors provide a safe and efficient method for reconstituting these drugs, ensuring accurate dosing and reducing the risk of contamination. The growing emphasis on infection prevention and control in healthcare settings is another key growth driver, as vial adaptors help minimize the risk of microbial contamination and ensure the sterility of drug products during preparation and administration.

Another significant growth driver is the increasing adoption of needle-free and closed-system transfer devices (CSTDs) in response to the need for safer drug handling practices. Needle-free vial adaptors are designed to eliminate the use of needles during drug reconstitution and transfer, reducing the risk of needlestick injuries and accidental exposures. CSTDs, which include vial adaptors, are widely used in the handling of hazardous drugs such as chemotherapy agents, where safety is paramount. The growing awareness of needlestick injuries and their potential health risks has led to increased regulatory support for needle-free systems, further driving the adoption of vial adaptors in both hospital and outpatient settings. Additionally, the expansion of healthcare infrastructure and the rising healthcare expenditure in emerging markets, such as Asia-Pacific and Latin America, are creating new opportunities for the growth of the vial adaptor market. As these regions invest in improving access to advanced healthcare solutions and expanding their pharmaceutical manufacturing capabilities, the demand for vial adaptors is expected to increase significantly.

The global vial adaptors market is also benefiting from the trend towards standardization and automation in drug reconstitution and administration processes. Pharmaceutical companies are increasingly incorporating vial adaptors into their drug delivery systems to ensure consistent product quality and simplify the reconstitution process for end-users. This trend is particularly strong in the development of combination products, such as pre-filled syringes and pen injectors, where vial adaptors are used to facilitate mixing and transfer. As technology continues to advance and the demand for biologic therapies grows, the global vial adaptors for reconstitution drug market is poised for sustained growth, driven by a dynamic interplay of innovation, regulatory support, and evolving healthcare practices.

SCOPE OF STUDY:

The report analyzes the Vial Adaptors for Reconstitution Drug market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene, Other Materials); Therapeutic Area (Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health, Other Therapeutic Areas)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Sensile Medical AG
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vial Adaptors for Reconstitution Drug - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Efficient Drug Reconstitution Solutions Drives Growth of Vial Adaptors Market
    • Increased Adoption of Vial Adaptors in Biopharmaceutical and Injectable Drug Administration Expands Addressable Market
    • Surge in Demand for Vial Adaptors in Home Healthcare and Self-Administration Applications Fuels Market Growth
    • Growing Focus on Reducing Medication Errors and Contamination Strengthens Business Case for Vial Adaptors
    • Rising Use of Vial Adaptors in Single-Dose and Multi-Dose Vials Sets the Stage for Market Growth
    • Technological Innovations in Needle-Free and Ventilated Vial Adaptors Propel Market Growth
    • Increased Utilization of Vial Adaptors in Critical Care and Emergency Medicine Expands Market Opportunities
    • Surge in Adoption of Vial Adaptors in Chemotherapy and Oncology Drug Administration Fuels Market Growth
    • Technological Advancements in Tamper-Proof and Locking Vial Adaptor Systems Propel Market Expansion
    • Growing Use of Vial Adaptors in Reconstitution of Vaccines and Biologics Strengthens Business Case
    • Increased Focus on Reducing Drug Waste and Optimizing Dosing Accuracy Drives Adoption of Vial Adaptors
    • Surge in Demand for Vial Adaptors in Closed System Drug Transfer Devices (CSTDs) Expands Market Opportunities
    • Rising Adoption of Vial Adaptors in Hormone and Hormone Replacement Therapies Fuels Market Demand
    • Technological Innovations in Luer-Lock and Swabbable Vial Adaptors Propel Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vial Adaptors for Reconstitution Drug Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vial Adaptors for Reconstitution Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polycarbonate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polycarbonate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polycarbonate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Silicon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polyethylene Teraphthalate Glycol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polyethylene Teraphthalate Glycol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Polyethylene Teraphthalate Glycol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Polyethylene by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Polyethylene by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Polyethylene by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Metabolic Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Metabolic Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Metabolic Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • JAPAN
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • CHINA
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • EUROPE
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Vial Adaptors for Reconstitution Drug by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • FRANCE
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • GERMANY
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vial Adaptors for Reconstitution Drug Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2015, 2025 & 2030

IV. COMPETITION